| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |